News
🇪🇺 EMA Page 15Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 169–180 of 353 articles
Stoke Therapeutics Zorevunersen Shows Promise for Dravet Syndrome Treatment Ahead of Q1 2026 Results
uniQure AMT-130 Gene Therapy Advances Toward UK Approval for Huntington's Disease Treatment
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins as Strategic Adviser for DCVax Cancer Vaccine Development
Cerus Corporation INTERCEPT Blood System Advances Through European Regulatory Review and Phase 3 Trials
Bio-Rad Q1 2026 Results Show IVDR Compliance Costs Impact European Diagnostics Operations
Alkeus Pharmaceuticals Presents Gildeuretinol Data for Stargardt Disease at ARVO 2026
SetPoint Medical Begins Multiple Sclerosis Trial for Setpoint System Neuroimmune Therapy
Emergent BioSolutions Reports Q1 2026 Financial Results: Biodefense Company Updates Revenue Performance
Telix Pharmaceuticals' TLX101-Px (Pixlumi) Brain Cancer Imaging Drug Accepted for European Review
EU Biopharma Clinical Trials: AI & Gene Therapy Surge
HUTCHMED's Sovleplenib Receives Priority Review and Breakthrough Designation in China for Rare Blood Disorder
FDA Real-World Evidence Framework Shifts $10B Toward Validated Medtech Platforms Like VentriPoint